T1	Participants 35 57	antiretroviral therapy
T2	Participants 180 241	HIV-infected patients initiating antiretroviral therapy (ART)
T3	Participants 384 419	106 ART-naive HIV-infected subjects
T4	Participants 1581 1657	ART-naive subjects receiving either EFV-based regimen or LPV/r-based regimen
